Bleakley Financial Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5,302
| Closed | -$3.78M | – | 879 |
|
|
2024
Q4 | $3.78M | Sell |
5,302
-613
| -10% | -$437K | 0.11% | 152 |
|
|
2024
Q3 | $6.22M | Sell |
5,915
-7,714
| -57% | -$8.11M | 0.19% | 94 |
|
|
2024
Q2 | $14.3M | Sell |
13,629
-751
| -5% | -$789K | 0.41% | 41 |
|
|
2024
Q1 | $13.8M | Buy |
14,380
+5,403
| +60% | +$5.2M | 0.4% | 43 |
|
|
2023
Q4 | $7.88M | Buy |
8,977
+860
| +11% | +$755K | 0.25% | 76 |
|
|
2023
Q3 | $6.68M | Sell |
8,117
-3,400
| -30% | -$2.8M | 0.24% | 83 |
|
|
2023
Q2 | $8.28M | Buy |
11,517
+188
| +2% | +$135K | 0.26% | 77 |
|
|
2023
Q1 | $9.31M | Buy |
11,329
+437
| +4% | +$359K | 0.31% | 66 |
|
|
2022
Q4 | $7.86M | Buy |
+10,892
| New | +$7.86M | 0.28% | 69 |
|